US Pharma MarketingK Health is eyeing an IPO by 2029
K Health raises $59M Series G at an $859M valuation and targets a 2028-29 IPO once it reaches 25-30 health systems. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for…
K Health is gearing up for a future public-market debut, CEO Allon Bloch said after a recent raise.
The virtual care company, which uses AI to help patients and clinicians sort through and act on ...
Source: Endpoints News